203 related articles for article (PubMed ID: 23881886)
41. [Relations of model and drug-induced psychoses to schizophrenic diseases].
Hermle L; Spitzer M; Borchardt D; Gouzoulis E
Fortschr Neurol Psychiatr; 1992 Oct; 60(10):383-92. PubMed ID: 1427555
[TBL] [Abstract][Full Text] [Related]
42. Psychotic Disorders in Patients Who Use Synthetic Cannabinoids.
Skryabin VY; Vinnikova MA
J Psychiatr Pract; 2019 Nov; 25(6):485-490. PubMed ID: 31821228
[TBL] [Abstract][Full Text] [Related]
43. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
[TBL] [Abstract][Full Text] [Related]
44. Spice-y Kidney Failure: A Case Report and Systematic Review of Acute Kidney Injury Attributable to the Use of Synthetic Cannabis.
Zarifi C; Vyas S
Perm J; 2017; 21():. PubMed ID: 28488989
[TBL] [Abstract][Full Text] [Related]
45. Acute psychosis following ingestion of 'Rapture'.
Austin H; Monasterio E
Australas Psychiatry; 2004 Dec; 12(4):406-8. PubMed ID: 15715818
[TBL] [Abstract][Full Text] [Related]
46. The phenomenology of the psychotic break and Huxley's trip: substance use and the onset of psychosis.
Nelson B; Sass LA
Psychopathology; 2008; 41(6):346-55. PubMed ID: 18765960
[TBL] [Abstract][Full Text] [Related]
47. [Flashback following use of cannabis--a review].
Fischer J; Täschner KL
Fortschr Neurol Psychiatr; 1991 Nov; 59(11):437-46. PubMed ID: 1761271
[TBL] [Abstract][Full Text] [Related]
48. [Forensic psychiatric expert evaluation of so-called drug-induced psychoses].
Hollweg M; Soyka M; Nedopil N
Psychiatr Prax; 1995 Sep; 22(5):197-200. PubMed ID: 7480371
[TBL] [Abstract][Full Text] [Related]
49. Ischemic stroke associated with the use of a synthetic cannabinoid (spice).
Moeller S; Lücke C; Struffert T; Schwarze B; Gerner ST; Schwab S; Köhrmann M; Machold K; Philipsen A; Müller HH
Asian J Psychiatr; 2017 Feb; 25():127-130. PubMed ID: 28262132
[TBL] [Abstract][Full Text] [Related]
50. Psychiatric sequelae of Spice, K2, and synthetic cannabinoid receptor agonists.
Benford DM; Caplan JP
Psychosomatics; 2011; 52(3):295. PubMed ID: 21565605
[No Abstract] [Full Text] [Related]
51. "Spice" girls: synthetic cannabinoid intoxication.
Schneir AB; Cullen J; Ly BT
J Emerg Med; 2011 Mar; 40(3):296-9. PubMed ID: 21167669
[TBL] [Abstract][Full Text] [Related]
52. Treatment of refractory substance-induced psychosis in adolescent males with a genetic predisposition to mental illness.
Rahmani M; Paul S; Nguyen ML
Int J Adolesc Med Health; 2014; 26(2):297-301. PubMed ID: 24762642
[TBL] [Abstract][Full Text] [Related]
53. Synthetic cannabinoid induced psychosis in a previously nonpsychotic patient.
Peglow S; Buchner J; Briscoe G
Am J Addict; 2012; 21(3):287-8. PubMed ID: 22494236
[No Abstract] [Full Text] [Related]
54. Psychopharmacological effects of cannabis.
Johnson BA
Br J Hosp Med; 1990 Feb; 43(2):114-6, 118-20, 122. PubMed ID: 2178712
[TBL] [Abstract][Full Text] [Related]
55. Analysis of synthetic cannabinoids in "spice-like" herbal highs: snapshot of the German market in summer 2011.
Simolka K; Lindigkeit R; Schiebel HM; Papke U; Ernst L; Beuerle T
Anal Bioanal Chem; 2012 Jul; 404(1):157-71. PubMed ID: 22710567
[TBL] [Abstract][Full Text] [Related]
56. Age at first tobacco use and risk of subsequent psychosis-related outcomes: A birth cohort study.
McGrath JJ; Alati R; Clavarino A; Williams GM; Bor W; Najman JM; Connell M; Scott JG
Aust N Z J Psychiatry; 2016 Jun; 50(6):577-83. PubMed ID: 25991762
[TBL] [Abstract][Full Text] [Related]
57. Simultaneous detection of multiple designer drugs in serum, urine, and CSF in a patient with prolonged psychosis.
Thornton SL; Lo J; Clark RF; Wu AH; Gerona RR
Clin Toxicol (Phila); 2012 Dec; 50(10):1165-8. PubMed ID: 23163617
[TBL] [Abstract][Full Text] [Related]
58. Synthetic cannabinoid-induced psychosis: two adolescent cases.
Oluwabusi OO; Lobach L; Akhtar U; Youngman B; Ambrosini PJ
J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):393-5. PubMed ID: 23083027
[No Abstract] [Full Text] [Related]
59. Exacerbation of psychosis triggered by a synthetic cannabinoid in a 70-year-old woman with Parkinson disease.
Udow SJ; Freitas ME; Fox SH; Lang AE
CMAJ; 2018 Jan; 190(2):E50-E52. PubMed ID: 29335263
[No Abstract] [Full Text] [Related]
60. [Synthetic cannabinoids--the new "legal high" drugs].
Berkovitz R; Arieli M; Marom E
Harefuah; 2011 Dec; 150(12):884-7, 937. PubMed ID: 22352277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
